TWST: Twist Bioscience Corporation Stock

by  •  • Comments Off on TWST: Twist Bioscience Corporation Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 1,796.98
Enterprise Value ($M) 1,530.72
Book Value ($M) 590.04
Book Value / Share 10.21
Price / Book 3.05
NCAV ($M) 247.46
NCAV / Share 4.28
Price / NCAV 7.26

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.24
Return on Equity (ROE) -0.29

Liquidity (mrq)
Quick Ratio 5.51
Current Ratio 5.98

Balance Sheet (mrq) ($M)
Current Assets 390.23
Assets 732.82
Liabilities 142.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 245.11
Operating Income -206.90
Net Income -204.62
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -142.47
Cash from Investing 50.61
Cash from Financing 0.91

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 9.49 -3.90
02-12 13G William Blair Investment Management, Llc 6.20
02-12 13G/A Nikko Asset Management Americas, Inc. 6.21 22.13
02-12 13G Artisan Partners Limited Partnership 6.40
02-09 13G/A Fmr Llc 0.53 -90.04
02-05 13G/A Sumitomo Mitsui Trust Holdings, Inc. 6.21 22.13
01-29 13G/A ARK Investment Management LLC 12.51 7.65
01-25 13G/A State Street Corp 5.83 -24.04
01-25 13G/A Jpmorgan Chase & Co 7.70 16.52
01-24 13G/A BlackRock Inc. 10.30 -4.29
01-22 13G/A Integrated Core Strategies (us) Llc 3.20 -40.21

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-11-21 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-06-05 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A
2023-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 142,298 494,992 28.75
2024-04-25 308,867 1,070,965 28.84
2024-04-24 228,144 616,011 37.04
2024-04-23 116,590 359,597 32.42
2024-04-22 175,615 382,286 45.94

(click for more detail)

Similar Companies
TRML – Tourmaline Bio, Inc. TSHA – Taysha Gene Therapies, Inc.
TSVT – 2seventy bio, Inc. TXMD – TherapeuticsMD, Inc.
TYRA – Tyra Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io